The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancer

por Michaleas, S., Moreno Oliver, A., Mueller-Berghaus, J., Sarac, S.B., van der Elst, M.E., Müller-Egert, S., Zander, H., Enzmann, H., Pignatti, F.
Publicado 2022